QIAGEN powered by
Advancing Clinical NGS: An integrated bioinformatics workflow for cancer genome and exome sequencing

QIAGEN Digital Insights Wednesday, February 14, 2024

Genome and exome sequencing is transforming cancer diagnostics and care. In the first installment of our Advancing Clinical NGS series,…

Learn what’s new in QIAGEN CLC Genomics Workbench version 24

QIAGEN Digital Insights Tuesday, February 6, 2024

Discover how CLC continues to improve and develop new capabilities. We’re excited to reveal many new improvements and enhancements to…

With expert-curated databases, QIAGEN data is poised to support discovery and development of precision cancer therapies

QIAGEN Digital Insights Tuesday, January 30, 2024

Two expert-curated databases exclusively licensed through QIAGEN link sequence-level somatic mutation data to detailed molecular information about functional and clinical…

5 key factors when choosing a new clinical informatics platform

QIAGEN Digital Insights Tuesday, October 24, 2023

With recent announcements of software retirements in the clinical NGS industry, many clinical diagnostic labs are looking for new variant…

3 secrets for drug discovery using AI

QIAGEN Digital Insights Friday, October 13, 2023

Here’s the scenario – You’re a passionate scientist in a leading pharmaceutical company hoping to uncover a transformative drug candidate….

3 uses for AI-powered knowledge graphs in drug discovery

QIAGEN Digital Insights Monday, October 9, 2023

Let us help you bridge the gap between data quality and meaningful insights If you’re working in pharma or biotech,…

Maximize your pathway analysis: 5 hidden gems in IPA

QIAGEN Digital Insights Thursday, September 28, 2023

Become a pathway analysis expert with these powerful tools you didn’t know about We’ve all been there. Huddled over a…

What’s new in the QCI Interpret Summer 2023 Release?

QIAGEN Digital Insights Friday, September 22, 2023

In its latest release, QCI Interpret advances market-leading NGS interpretation software with artificial intelligence-driven insights to enable clinical exome completeness…

Determining the clinical actionability of the ALK gene in lung cancer with the Human Somatic Mutation Database (HSMD)

QIAGEN Digital Insights Monday, August 7, 2023

Interpretation of genomic variants in tumor samples still presents a challenge in clinical settings. Variant interpretation is fragmented across disparate…

Free isn’t better; better is better

QIAGEN Digital Insights Sunday, July 9, 2023

Open-sourced software comes with a variety of risks. To more effectively advance your research, here’s where to turn instead. “Download…

A partnership that empowers your cell line selection

QIAGEN Digital Insights Thursday, July 6, 2023

We unite with ATCC to deliver a transformative database of authenticated cell ‘omics data What powerful partnerships come to mind…

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing

QIAGEN Digital Insights Wednesday, June 14, 2023

QCI Interpret for Oncology will support the Danish National Genome Center’s new national initiative—one of Europe’s largest precision oncology projects…